{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T18:18:58Z","timestamp":1773944338186,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Merz Center for Quality and Outcomes Resesarch in Dermatologic Surgery"},{"name":"IMPROVED Group"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1554-3","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T16:33:21Z","timestamp":1472834001000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Development of a core outcome set for clinical trials in rosacea: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey"],"prefix":"10.1186","volume":"17","author":[{"given":"Sanjana","family":"Iyengar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula R.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Johannsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian A.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Sobanko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd V.","family":"Cartee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schlessinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"issue":"6","key":"1554_CR1","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40257-015-0156-2","volume":"16","author":"LM Gold","year":"2015","unstructured":"Gold LM, Draelos ZD. New and emerging treatments for rosacea. Am J Clin Dermatol. 2015;16(6):457\u201361.","journal-title":"Am J Clin Dermatol"},{"issue":"6 Suppl 1","key":"1554_CR2","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","volume":"69","author":"J Tan","year":"2013","unstructured":"Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):S27\u201335.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1554_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","volume":"19","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol. 2005;19(3):273\u201385.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1554_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12385","volume":"169","author":"J Tan","year":"2013","unstructured":"Tan J, Blume-Peytavi U, Ortonne JP, Wilhelm K, Marticou L, Baltas E, Rivier M, Petit L, Martel P. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol. 2013;169(3):555\u201362.","journal-title":"Br J Dermatol"},{"issue":"2","key":"1554_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jaad.2015.03.031","volume":"73","author":"J Dosal","year":"2015","unstructured":"Dosal J, Keri J. Rosacea and cardiovascular disease: is there an association? J Am Acad Dermatol. 2015;73(2):308\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1554_CR6","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S1470-2045(15)00129-1","volume":"16","author":"S Bagcchi","year":"2015","unstructured":"Bagcchi S. Rosacea associated with increased risk of some cancers. Lancet Oncol. 2015;16(8):e382.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1554_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaad.2015.11.004","volume":"74","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol. 2016;74(4):667\u201372. e1.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1554_CR8","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","volume":"22","author":"J Spoendlin","year":"2016","unstructured":"Spoendlin J, Karatas G, Furlano RI, Jick SS, Meier CR. Rosacea in patients with ulcerative colitis and Crohn\u2019s disease: a population-based case-control study. Inflamm Bowel Dis. 2016;22(3):680\u20137.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"1554_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.jaad.2014.05.044","volume":"71","author":"J Tan","year":"2014","unstructured":"Tan J, Liu H, Leyden JJ, Leoni MJ. Reliability of Clinician Erythema Assessment grading scale. J Am Acad Dermatol. 2014;71(4):760\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"1554_CR10","unstructured":"Mirvaso. European Medicines Agency. 2014. \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Summary_for_the_public\/human\/002642\/WC500163123.pdf\n                    \n                  . Accessed 8 Aug 2016."},{"key":"1554_CR11","unstructured":"ClinicalTrials.gov. \n                    https:\/\/clinicaltrials.gov\n                    \n                  . Accessed 20 Apr 2016."},{"key":"1554_CR12","first-page":"CD003262","volume":"4","author":"EJ Zuuren van","year":"2015","unstructured":"van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database Syst Rev. 2015;4:CD003262.","journal-title":"Cochrane Database Syst Rev"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","volume":"340","author":"JJ Kirkham","year":"2010","unstructured":"Kirkham JJ, Dwan KM, Altman DA, Gamble C, Dodd S, Smyth R, Williamson PR. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ. 2010;340:c365.","journal-title":"BMJ"},{"key":"1554_CR14","unstructured":"COMET Initiative. \n                    http:\/\/www.comet-initiative.org\/\n                    \n                  . Accessed 20 Apr 2016."},{"key":"1554_CR15","unstructured":"Cochrane Skin Group - Core Outcome Set Initiative (CSG-COUSIN). \n                    https:\/\/www.uniklinikumdresden.de\/COUSIN\/\n                    \n                  . Accessed 21 Apr 2016."},{"issue":"6","key":"1554_CR16","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/j.1365-2133.2010.10054.x","volume":"163","author":"J Schmitt","year":"2010","unstructured":"Schmitt J, Williams HC. HOME Development Group. Harmonising Outcome Measures for Eczema (HOME). Report from the first international consensus meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol. 2010;163(6):1166\u20138.","journal-title":"Br J Dermatol"},{"issue":"9","key":"1554_CR17","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1398-9995.2012.02874.x","volume":"67","author":"J Schmitt","year":"2012","unstructured":"Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, Schram M, Allsopp R, Aoki V, Apfelbacher C, Bruijnzeel-Koomen C, Bruin-Weller M, Charman C, Cohen A, Dohil M, Flohr C, Furue M, Gieler U, Hooft L, Humphreys R, Ishii HA, Katayama I, Kouwenhoven W, Langan S, Lewis-Jones S, Merhand S, Murota H, Murrell DF, Nankervis H, Ohya Y, Oranje A, Otsuka H, Paul C, Rosenbluth Y, Saeki H, Schuttelaar ML, Stalder JF, Svensson A, Takaoka R, Wahlgren CF, Weidinger S, Wollenberg A, Williams H. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67(9):1111\u20137.","journal-title":"Allergy"},{"key":"1554_CR18","unstructured":"Harmonising Outcome Measures for Eczema. (2013). Minutes of the HOME III Meeting. Retrieved from \n                    http:\/\/www.nottingham.ac.uk\/homeforeczema\/documents\/minutes-home-iii-final.pdf\n                    \n                  ."},{"issue":"4","key":"1554_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jaci.2014.07.043","volume":"134","author":"J Schmitt","year":"2014","unstructured":"Schmitt J, Spuls PI, Thomas KS, Simpson E, Furue M, Deckert S, Dohil M, Apfelbacher C, Singh JA, Chalmers J, Williams HC. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134(4):800\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1554_CR20","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/bjd.13237","volume":"171","author":"JR Chalmers","year":"2014","unstructured":"Chalmers JR, Schmitt J, Apfelbacher C, Dohil M, Eichenfield LF, Simpson EL, Singh J, Spuls P, Thomas KS, Admani S, Aoki V, Ardeleanu M, Barbarot S, Berger T, Bergman JN, Block J, Borok N, Burton T, Chamlin SL, Deckert S, DeKlotz CC, Graff LB, Hanifin JM, Hebert AA, Humphreys R, Katoh N, Kisa RM, Margolis DJ, Merhand S, Minnillo R, Mizutani H, Nankervis H, Ohya Y, Rodgers P, Schram ME, Stalder JF, Svensson A, Takaoka R, Teper A, Tom WL, von Kobyletzki L, Weisshaar E, Zelt S, Williams HC. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema\/dermatitis clinical trials (HOME). Br J Dermatol. 2014;171(6):1318\u201325.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1554_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jid.2014.320","volume":"135","author":"J Schmitt","year":"2015","unstructured":"Schmitt J, Apfelbacher C, Spuls PI, Thomas KS, Simpson EL, Furue M, Chalmers J, Williams HC. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Invest Dermatol. 2015;135(1):24\u201330.","journal-title":"J Invest Dermatol"},{"key":"1554_CR22","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s13063-015-1072-8","volume":"16","author":"A Moza","year":"2015","unstructured":"Moza A, Benstoem C, Autschbach R, et al. A core outcome set for all types of cardiac surgery effectiveness trials: a study protocol for an international eDelphi survey to achieve consensus on what to measure and the subsequent selection of measurement instruments. Trials. 2015;16:545.","journal-title":"Trials"},{"issue":"4","key":"1554_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395\u2013400.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"1554_CR24","doi-asserted-by":"publisher","first-page":"e0129514","DOI":"10.1371\/journal.pone.0129514","volume":"10","author":"NL Harman","year":"2015","unstructured":"Harman NL, Bruce IA, Kirkham JJ, Tierney S, Callery P, O\u2019Brien K, Bennett AMD, Chorbachi R, Hall PN, Harding-Bell A, Parfect VH, Rumsey N, Sell D, Sharma R, Williamson PR. The importance of integration of stakeholder views in core outcome set development: otitis media with effusion in children with cleft palate. PLoS One. 2015;10(6):e0129514.","journal-title":"PLoS One"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-016-1554-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1554-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1554-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T10:09:00Z","timestamp":1487671740000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1554-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1554-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"article-number":"429"}}